Nutrient removal and recovery from wastewater by microbial fuel cell-based systems - A review.

Microbial fuel cell (MFC) is a green innovative technology that can be employed for nutrient removal/recovery as well as for energy production from wastewater. This paper summarizes the recent advances in the use of MFCs for nutrient removal/recovery. Different configurations of MFCs used for nutrient removal are first described. Different types of nutrient removal/recovery mechanisms such as precipitation, biological uptake by microalgae, nitrification, denitrification and ammonia stripping occurring in MFCs are discussed. Recovery of nutrients as struvite or cattiite by precipitation, as microalgal biomass and as ammonium salts are common. This review shows that while higher nutrient removal/recovery is possible with MFCs and their modifications compared to other techniques as indicated by many laboratory studies, field-scale studies and optimization of operational parameters are needed to develop efficient MFCs for nutrient removal and recovery and electricity generation from different types of wastewaters.

Development of an Anti-Atherosclerotic Polyherbal Formulation: GSTC3.

A polyherbal formulation consisting of different proportions of Commiphora mukul (Hook ex Stocks) Eng., Salacia reticulata Wight, Terminalia arjuna (Roxb.) Wight & Arn, and Curcuma longa Linn extracts was tested for free-radical scavenging and anti-lipid peroxidative effects on serum and platelets in vitro. The most active formulation (GSTC3) was evaluated for its hypolipidemic potential on a high-fat, high-cholesterol diet (HFD) fed to male Wistar rats for a period of 45 days. At a dose of 100 mg/kg body weight, GSTC3 decreased serum total cholesterol, low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), triglycerides, and phospholipids similar to standard atorvastatin while maintaining high-density lipoprotein (HDL) at normal levels. Significantly lower levels of thiobarbituric acid-reactive substances (TBARS) were observed in both the liver and sera of rats treated with GSTC3. Although the phospholipid levels in liver remained unchanged, lower values of LDL, VLDL, and atherogenic index of plasma as well as higher HMG-CoA/ mevalonate ratios suggested a significant hypolipidemic effect for GSTC3, possibly by partial inhibition of HMG-CoA reductase activity. The histopathological analysis of liver tissue did not reveal lipid accumulation or indicate tissue damage. Overall, the results of this study suggest the hypolipidemic and anti-atherogenic efficacy of a nontoxic herbal formulation.